| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/18/2012 | CN102584823A Preparation method of vobasine |
| 07/18/2012 | CN102584822A 1,3-benzodiazole naphthalimide derivative with c, preparation method and appliance thereof |
| 07/18/2012 | CN102584821A Pyridoindole derivative and antibacterial application thereof |
| 07/18/2012 | CN102584820A Preparation method for 5-bromo-7-azaindole |
| 07/18/2012 | CN102584819A Salt of carbostyril formic acid compound as well as preparation method and application of salt |
| 07/18/2012 | CN102584818A Novel paliperidone medicinal eutectic and preparation method thereof |
| 07/18/2012 | CN102584817A Preparation method of 2-(imidazo[1,2-a]pyridin-3-radical)acetic acid monohydrochloride and application thereof |
| 07/18/2012 | CN102584816A Method for preparing polycycle tertiary amine |
| 07/18/2012 | CN102584799A Aromatic nitrogenous six-membered ring compounds |
| 07/18/2012 | CN102101861B Synthesis and process method of nitrogen-containing bis-heterocyclic medicine intermediate |
| 07/18/2012 | CN101899044B Method for synthesizing Gemifloxacin main ring compound |
| 07/18/2012 | CN101863887B Matrine derivative and preparation method thereof |
| 07/18/2012 | CN101516881B 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 07/18/2012 | CN101124229B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 07/17/2012 | US8222416 Azaindole glucokinase activators |
| 07/17/2012 | US8222407 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| 07/17/2012 | US8222405 Phenylalanine derivatives |
| 07/17/2012 | US8221903 Materials for N-type doping of the electron transporting layers in organic electronic devices |
| 07/17/2012 | CA2685674C Pyrazolo-pyridinone compounds, process for their preparation, and their pharmaceutical use |
| 07/17/2012 | CA2637658C Aurora kinase modulators and method of use |
| 07/12/2012 | WO2012094313A1 Pyrazole derivatives as erk inhibitors |
| 07/12/2012 | WO2012093708A1 Novel bicyclic compound or salt thereof |
| 07/12/2012 | WO2012093101A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| 07/12/2012 | WO2012004802A8 Continuous flow process for the preparation of sulphoxide compounds |
| 07/12/2012 | US20120178937 Process for the preparation of alosetron |
| 07/12/2012 | US20120178934 N- [2-hydroxycarbamoyl-2- (piperazinyl) ethyl] benzamide compounds, their preparation and their use as tace inhibitors |
| 07/12/2012 | US20120178780 Raf kinase inhibitors |
| 07/12/2012 | US20120178779 Fused heterocyclic compound and use thereof |
| 07/12/2012 | US20120178778 Pyrazolopyridines |
| 07/12/2012 | US20120178776 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators |
| 07/12/2012 | US20120178760 Heterocyclic-Fused Pyrazolo[4,3-c] Pyridin-3-One M1 Receptor Positive Allosteric Modulators |
| 07/12/2012 | US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 07/12/2012 | US20120178751 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives |
| 07/12/2012 | US20120178748 Heteroaryl compounds and methods of use thereof |
| 07/12/2012 | US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 07/12/2012 | US20120178723 Heteroaryls and uses thereof |
| 07/12/2012 | US20120178713 Phenyl sulphonamides as modulators of ion channels |
| 07/12/2012 | US20120175599 Compound having carbazole ring structure, and organic electroluminescent device |
| 07/12/2012 | US20120174324 Dyes for polymer coloration, their preparation and their use |
| 07/12/2012 | DE102011008352A1 5-([1,2,3]Triazol-4-yl)-7H-pyrrolo-[2,3-d]pyrimidinderivate 5 - ([1,2,3] triazol-4-yl) -7H-pyrrolo [2,3-d] pyrimidine derivatives |
| 07/12/2012 | CA2824013A1 Novel bicyclic compound or salt thereof |
| 07/12/2012 | CA2823665A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| 07/11/2012 | EP2474547A2 Process for the Synthesis of Moxifloxacin Hydrochloride |
| 07/11/2012 | EP2474546A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 07/11/2012 | EP2474545A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/11/2012 | EP2474540A1 Gpr119 agonist |
| 07/11/2012 | EP2473510A1 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 07/11/2012 | EP2473509A1 Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 07/11/2012 | EP2473508A1 Compounds and compositions as tlr activity modulators |
| 07/11/2012 | EP2473500A2 Benzimidazole derivatives |
| 07/11/2012 | EP2473490A1 (thio)morpholine derivatives as s1p modulators |
| 07/11/2012 | EP2473056A1 Chemical compounds |
| 07/11/2012 | EP2473055A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 07/11/2012 | EP2473049A1 Bruton's tyrosine kinase inhibitors |
| 07/11/2012 | EP2473048A1 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators |
| 07/11/2012 | EP2473041A1 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
| 07/11/2012 | EP2318409B1 Method for producing 3,7-diaza-bicyclo[3.3.1]nonane compounds |
| 07/11/2012 | EP2313408B1 Diketopiperidine derivatives as hiv attachment inhibitors |
| 07/11/2012 | EP2138489B1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |
| 07/11/2012 | EP1940401B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/11/2012 | EP1866310B1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists |
| 07/11/2012 | EP1470121B1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/11/2012 | CN202332974U 一种叠层有机薄膜太阳能电池 A laminated organic thin film solar cell |
| 07/11/2012 | CN102575155A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/11/2012 | CN102574857A Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 07/11/2012 | CN102574854A Macrocyclic integrase inhibitors |
| 07/11/2012 | CN102574853A Heterocyclic oxime compounds |
| 07/11/2012 | CN102574852A AKT inhibitors |
| 07/11/2012 | CN102574851A Fused heterocyclic ring derivative and use thereof |
| 07/11/2012 | CN102574850A Process for the preparation of cathepsin S inhibitors |
| 07/11/2012 | CN102574849A Herbicidal compounds |
| 07/11/2012 | CN102574848A Materials for organic electroluminescent devices |
| 07/11/2012 | CN102574847A Compounds and compositions as syk kinase inhibitors |
| 07/11/2012 | CN102574846A Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 07/11/2012 | CN102574845A 1h-imidazo[4,5-c]quinolinone derivatives |
| 07/11/2012 | CN102574842A Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 07/11/2012 | CN102574836A Aminopyrazole derivative |
| 07/11/2012 | CN102574816A Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 07/11/2012 | CN102574815A Mesoionic pesticides |
| 07/11/2012 | CN102574813A Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component |
| 07/11/2012 | CN102574807A Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes |
| 07/11/2012 | CN102574799A Process for the manufacture of pharmaceutically active compounds |
| 07/11/2012 | CN102574797A Benzo[k]fluoranthene derivative and organic electroluminescence element containing same |
| 07/11/2012 | CN102574786A Dihydroorotate dehydrogenase inhibitors |
| 07/11/2012 | CN102573994A Novel bicyclic urea compounds |
| 07/11/2012 | CN102558178A Tabersonine derivative, pharmaceutical compositions, preparing method and medical application thereof |
| 07/11/2012 | CN102558177A Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 07/11/2012 | CN102558176A Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
| 07/11/2012 | CN102558175A Phosphorescent compound and organic electroluminescent device using the same |
| 07/11/2012 | CN102558174A New pyrazolo[4,3-c]pyridine compound and synthesis method thereof |
| 07/11/2012 | CN102558173A Compound inhibiting conduction of WNT signal, and composition and application thereof |
| 07/11/2012 | CN102558172A 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds, dimer compounds of 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds, and preparation method and use of 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds and dimer compounds of 5,8-disubstituted-1,6-naphthyridine-7-carbonyl amide compounds |
| 07/11/2012 | CN102558171A Preparation method of intermediate of olprinone hydrochloride |
| 07/11/2012 | CN102558147A Compound, and preparation method and application thereof |
| 07/11/2012 | CN102558140A Derivatives of 4-piperazin-1-1-yl-4-benzo [b] thiophene suitable for the treatment of cns disorders |
| 07/11/2012 | CN102557982A Certain chemical entities, compositions, and methods |
| 07/11/2012 | CN102002042B Method for extracting voacangine from Africa voacanga seeds |
| 07/11/2012 | CN101830935B Solanum cathayanum alkaloid extract and preparation method and application thereof |
| 07/11/2012 | CN101353344B Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 07/10/2012 | US8217169 Coupling agents for peptide synthesis |